Biomere vs GemPharmatech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biomere/gempharmatech

Category	Biomere	GemPharmatech
Listed site	cro	cro
Summary	Boston-area preclinical CRO specializing in non-GLP PK/PD and early toxicology studies in rodent and large animal models, including primates, with AAALAC accreditation and extensive vivarium capacity.	GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.
Services	In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Specialized & Large-Animal Models	Specialized & Large-Animal Models In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies In Vitro Pharmacology Preclinical In Vitro Studies Target Identification & Validation
Modalities	Small Molecule Biologics (Other) Gene Therapy	Biologics (Monoclonal Antibodies)
Indications	Ophthalmology Neurology Metabolic Oncology	Oncology Immunology Neurology Metabolic Cardiovascular Infectious Disease Rare Disease
Locations	Headquarters, Worcester, MA, United States West Coast Facility, Richmond, CA, United States	Headquarters, Jiangsu, China
Certifications	AAALAC · Identifier: AAALAC accredited OLAW · Identifier: OLAW Assured DEA · Identifier: DEA Licensed USDA · Identifier: USDA Registered	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.